Blandine Comte

Dr. Blandine Comte

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
EPEstelle Pujos-Guillot
Estelle Pujos-Guillot
MPMélanie Pétéra
Mélanie Pétéra
JJJérémie Jacquemin
Jérémie Jacquemin
DCDelphine Centeno
Delphine Centeno
BLBernard Lyan
Bernard Lyan
BCBlandine Comte
Blandine Comte
Aging is a dynamic process depending on intrinsic and extrinsic factors and its evolution is a continuum of transitions, involving multifaceted processes at multiple levels. It is recognized that frailty and sarcopenia are shared by the major age-related diseases thus contributing to elderly morbidity and mortality. Pre-frailty is still not well understood but it has been associated with global imbalance in several physiological systems, including inflammation, and in nutrition. Due to the complex phenotypes and underlying pathophysiology, the need for robust and multidimensional biomarkers is essential to move toward more personalized care. The objective of the present study was to better characterize the complexity of pre-frailty phenotype using untargeted metabolomics, in order to identify specific biomarkers, and study their stability over time. The approach was based on the NU-AGE project (clinicaltrials.gov, NCT01754012) that regrouped 1,250 free-living elderly people (65–79 y.o., men and women), free of major diseases, recruited within five European centers. Half of the volunteers were randomly assigned to an intervention group (1-year Mediterranean type diet). Presence of frailty was assessed by the criteria proposed by Fried et al. (2001). In this study, a sub-cohort consisting in 212 subjects (pre-frail and non-frail) from the Italian and Polish centers were selected for untargeted serum metabolomics at T0 (baseline) and T1 (follow-up). Univariate statistical analyses were performed to identify discriminant metabolites regarding pre-frailty status. Predictive models were then built using linear logistic regression and ROC curve analyses were used to evaluate multivariate models. Metabolomics enabled to discriminate sub-phenotypes of pre-frailty both at the gender level and depending on the pre-frailty progression and reversibility. The best resulting models included four different metabolites for each gender. They showed very good prediction capacity with AUCs of 0.93 (95% CI = 0.87–1) and 0.94 (95% CI = 0.87–1) for men and women, respectively. Additionally, early and/or predictive markers of pre-frailty were identified for both genders and the gender specific models showed also good performance (three metabolites; AUC = 0.82; 95% CI = 0.72–0.93) for men and very good for women (three metabolites; AUC = 0.92; 95% CI = 0.86–0.99). These results open the door, through multivariate strategies, to a possibility of monitoring the disease progression over time at a very early stage.

16 November 2020 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
Haiying WangHaiying Wang
Haiying Wang
EPEstelle Pujos-Guillot
Estelle Pujos-Guillot
BCBlandine Comte
Blandine Comte
JMJoão Luís De Miranda
João Luís De Miranda
VSVojtech Spiwok
Vojtech Spiwok
Huiru ZhengHuiru Zheng
Huiru Zheng
Systems medicine (SM) has emerged as a powerful tool for studying the human body at the systems level with the aim of improving our understanding, prevention and treatment of complex diseases. Being able to automatically extract relevant features needed for a given task from high-dimensional, heterogeneous data, deep learning (DL) holds great promise in this endeavour. This review paper addresses the main developments of DL algorithms and a set of general topics where DL is decisive, namely, within the SM landscape. It discusses how DL can be applied to SM with an emphasis on the applications to predictive, preventive and precision medicine. Several key challenges have been highlighted including delivering clinical impact and improving interpretability. We used some prototypical examples to highlight the relevance and significance of the adoption of DL in SM, one of them is involving the creation of a model for personalized Parkinson’s disease. The review offers valuable insights and informs the research in DL and SM.

1 July 2020 in Network and Systems Medicine
Verified
Journal Article
Open access
BCBlandine Comte
Blandine Comte
JBJan Baumbach
Jan Baumbach
Arriel BenisArriel Benis
Arriel Benis
JBJosé Basílio
José Basílio
Nataša DebeljakNataša Debeljak
Nataša Debeljak
HSHarald H.H.W. Schmidt
Harald H.H.W. Schmidt
Introduction: Network and systems medicine has rapidly evolved over the past decade, thanks to computational and integrative tools, which stem in part from systems biology. However, major challenges and hurdles are still present regarding validation and translation into clinical application and decision making for precision medicine. Methods: In this context, the Collaboration on Science and Technology Action on Open Multiscale Systems Medicine (OpenMultiMed) reviewed the available advanced technologies for multidimensional data generation and integration in an open-science approach as well as key clinical applications of network and systems medicine and the main issues and opportunities for the future. Results: The development of multi-omic approaches as well as new digital tools provides a unique opportunity to explore complex biological systems and networks at different scales. Moreover, the application of findable, applicable, interoperable, and reusable principles and the adoption of standards increases data availability and sharing for multiscale integration and interpretation. These innovations have led to the first clinical applications of network and systems medicine, particularly in the field of personalized therapy and drug dosing. Enlarging network and systems medicine application would now imply to increase patient engagement and health care providers as well as to educate the novel generations of medical doctors and biomedical researchers to shift the current organ- and symptom-based medical concepts toward network- and systems-based ones for more precise diagnoses, interventions, and ideally prevention. Conclusion: In this dynamic setting, the health care system will also have to evolve, if not revolutionize, in terms of organization and management.

23 December 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
FCFrancesco Maria Calabrese
Francesco Maria Calabrese
APAnnalisa Porrelli
Annalisa Porrelli
Mirco VaccaMirco Vacca
Mirco Vacca
BCBlandine Comte
Blandine Comte
KNKatharina Nimptsch
Katharina Nimptsch
MAMaria De Angelis
Maria De Angelis
Low-grade inflammatory diseases revealed metabolic perturbations that have been linked to various phenotypes, including gut microbiota dysbiosis. In the last decade, metaproteomics has been used to investigate protein composition profiles at specific steps and in specific healthy/pathologic conditions. We applied a rigorous protocol that relied on PRISMA guidelines and filtering criteria to obtain an exhaustive study selection that finally resulted in a group of 10 studies, based on metaproteomics and that aim at investigating obesity and diabetes. This batch of studies was used to discuss specific microbial and human metaproteome alterations and metabolic patterns in subjects affected by diabetes (T1D and T2D) and obesity. We provided the main up- and down-regulated protein patterns in the inspected pathologies. Despite the available results, the evident paucity of metaproteomic data is to be considered as a limiting factor in drawing objective considerations. To date, ad hoc prepared metaproteomic databases collecting pathologic data and related metadata, together with standardized analysis protocols, are required to increase our knowledge on these widespread pathologies.

4 January 2019 in Discrete Applied Mathematics
Verified
Journal Article
Closed access
DGDhouha Grissa
Dhouha Grissa
BCBlandine Comte
Blandine Comte
MPMélanie Pétéra
Mélanie Pétéra
EPEstelle Pujos-Guillot
Estelle Pujos-Guillot
ANAmedeo Napoli
Amedeo Napoli

24 October 2019 in Metabolites
Verified
Journal Article
Open access
PDF file
SMStephanie Monnerie
Stephanie Monnerie
MPMelanie Petera
Melanie Petera
BLBernard Lyan
Bernard Lyan
PGPierrette GAUDREAU
Pierrette GAUDREAU
BCBlandine Comte
Blandine Comte
EPEstelle Pujos-Guillot
Estelle Pujos-Guillot
Metabolomics generates massive and complex data. Redundant different analytical species and the high degree of correlation in datasets is a constraint for the use of data mining/statistical methods and interpretation. In this context, we developed a new tool to detect analytical correlation into datasets without confounding them with biological correlations. Based on several parameters, such as a similarity measure, retention time, and mass information from known isotopes, adducts, or fragments, the algorithm principle is used to group features coming from the same analyte, and to propose one single representative per group. To illustrate the functionalities and added-value of this tool, it was applied to published datasets and compared to one of the most commonly used free packages proposing a grouping method for metabolomics data: ‘CAMERA’. This tool was developed to be included in Galaxy and is available in Workflow4Metabolomics.